Artificial intelligence (AI) is transforming the health care landscape, from diagnostics to drug development and clinical trials. As AI ...

The US FDA has issued guidance to limit lead levels in processed baby foods, aiming to reduce exposure by 20%-30%.

The document follows the agency’s first digital health advisory meeting and a final guidance on postmarket updates to AI ...

What Happened: The Food and Drug Administration (FDA) released new guidance regarding the registration and listing of ...

The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new ...

The agency issued final guidance that it estimated could reduce lead exposure from processed baby foods by about 20% to 30%.

The FDA recommendations apply to only professional oximeters used in hospitals, doctor's offices, and other medical settings.

Amid recent backlash stemming from market withdrawals and trial delays, the FDA seeks to further clarify its requirements for ...

The final guidance covers packaged processed foods that are represented or purported to be for babies and young children less ...

For the first time in history, the US Food and Drug Administration has established guidance for levels of lead in processed baby foods<a class="excerpt-read-more" href=" More ...

Final guidance from FDA affirms previously proposed caps for lead in packaged baby and toddler food that public health advocates complained did not go far enough – spurring calls for state action.

The FDA published its first draft guidance on the use of AI in the development of drugs and biological products ...